BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:54:00 PM | Browse: 955 | Download: 490
Publication Name World Journal of Gastroenterology
Manuscript ID 2895
Country/Territory China
Received
2013-03-22 11:20
Peer-Review Started
2013-03-24 09:02
To Make the First Decision
2013-04-03 09:11
Return for Revision
2013-04-15 18:41
Revised
2013-04-25 17:27
Second Decision
2013-06-03 16:06
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-06-04 09:41
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-06-28 10:40
Typeset the Manuscript
2013-07-18 16:48
Publish the Manuscript Online
2013-07-29 11:18
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Autobiography
Article Title Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments
Manuscript Source Invited Manuscript
All Author List Sheng-Li He, Jie Shen, Xian-Jun Sun, Xiao-Juan Zhu, Lu-Ming Liu and Jing-Cheng Dong
Funding Agency and Grant Number
Funding Agency Grant Number
Shanghai Municipal Health Bureau Outstanding Young Clinical Personal Training Project ZYSNXD-YL-YSZK025
Corresponding Author Dr. Sheng-Li He, Department of Hepato-Biliary and Pancreatic Oncology, Fudan University Shanghai Cancer Center, Minhang Branch, Shanghai 200240, China. hlshli@yeah.net
Key Words Hepatocellular carcinoma; Extrahepatic metastasis; Capecitabine; Oxaliplatin; Local treatments
Core Tip Distant metastases are still obstacles in improvement of outcome in hepatocellular carcinoma (HCC) patients after local treatment. Although, sorafenib is used as a standard systemic treatment for those patients, it is not suitable for patients with intermediate HCC who were not eligible to or failed in the locoregional therapy. This study reports the capecitabine and oxaliplatin regimen for extrahepatic metastasis after local treatment of HCC. The objective response rate was 21.9%, and 40.6% of patients had stable disease, and the median overall survival and the time to tumor progression were 4.2 and 9.2 mo, respectively. Furthermore, the result of this study showed that toxicity profile was tolerated well.
Publish Date 2013-07-29 11:18
Citation He SL, Shen J, Sun XJ, Zhu XJ, Liu LM, Dong JC. Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments. World J Gastroenterol 2013; 19(28): 4552-4558
URL http://www.wjgnet.com/1007-9327/full/v19/i28/4552.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i28.4552
Full Article (PDF) WJG-19-4552.pdf
Manuscript File 2895-Review.doc
Answering Reviewers 2895-Answering reviewers.pdf
Copyright License Agreement 2895-Copyright assignment.pdf
Peer-review Report 2895-Peer reviews.pdf
Scientific Editor Work List 2895-Scientific editor work list.doc